Massey partners to bring health information service to Petersburg library
Petersburg residents can now access current and accurate health information at their local library. The Petersburg Healthy Living and Learning Center at the Petersburg Central Library hosted a grand opening on October 1, 2012, in conjunction with National Health Literacy Month. The Center is the result of a partnership among the Library, Virginia Commonwealth University Massey Cancer Center and Crater Health District.
Researchers harness the immune system to improve stem cell transplant outcomes
A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system.
Translational research: from bench to bedside
Massey’s science-driven translational research – moving scientific discoveries from the laboratory into real-world patient applications – is one of the many reasons the National Cancer Institute recently awarded Massey a five-year renewal as one of only two NCI-designated Cancer Centers in Virginia. Often described as “bench-to-bedside” research, translational research involves several stages, including clinical trials, where consenting patients are given drugs, surgical procedures, devices or other interventions to treat cancer and are then closely monitored to determine side effects, effectiveness and other key findings.
Researcher Steven Grant awarded prestigious appointment, grant funding
VCU Massey Cancer Center researcher Steven Grant, M.D., was recently recognized with an appointment to a major cancer journal and continued financial support from the Leukemia and Lymphoma Society, for his world renown work in discovering new therapies for hematological malignancies. Grant is the Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research, co-leader and member of the Developmental Therapeutics program and member of the Cancer Cell Signaling program at VCU Massey Cancer Center.
Scientists devise new strategy to destroy multiple myeloma
A study published online in the journal Cancer Research details a dramatic increase in multiple myeloma cell death caused by a combination of the drugs obatoclax and flavopiridol. The researchers, led by Steven Grant, M.D., Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research, program co-leader and member of Developmental Therapeutics and member of the Cancer Cell Signaling program at VCU Massey Cancer Center, found that the two drugs worked together through different mechanisms to promote a form of cell suicide known as apoptosis.